PGHLNSEProcter & Gamble Health Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 6 Feb, 2026 · 14:44 IST

PGHL declares Rs.160 interim dividend, Q3 net profit dips to Rs.77.59 cr

PGHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.1%Reaction day
₹5235.00
prior close
₹5190.00
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.8%-0.3% vs market
Pharmaceuticals peers, median of 159sector-0.6%-0.5% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
+0.0
15m
+0.0
30m
-0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.1-0.8-0.3-0.6-0.5
Next day
+2.8+1.8+1.0+1.1+1.6
2d
+5.3+2.8+2.5+1.7+3.6
3d
+4.7+2.3+2.4+1.3+3.4
4d
-1.1+1.8-2.8+0.7-1.7
5d
-3.9+0.3-4.2+0.0-4.0
1w
-2.9+0.5-3.4-0.2-2.7
15d
-5.9-2.5-3.4-2.3-3.6
1m
-6.7-6.3-0.4-4.4-2.4
2m
-8.2-8.0-0.3-7.2-1.0
3m
+2.2+8.3-6.0+2.7-0.5
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q3 FY26 results. Revenue rose 20.7% YoY to Rs.373.86 cr but net profit fell 14.6% to Rs.77.59 cr. Interim dividend declared at Rs.160 per share including a Rs.50 one-time special dividend, totaling Rs.265.59 cr payout. Record date Feb 12, 2026, payment by March 4. 9M FY26 net profit up about 22% to Rs.232.31 cr.

Likely market impact

Special one-time dividend rewards holders; Q3 profit decline may pressure stock near term despite strong 9M growth.